Skip to content

Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects

Effect of Autologous Platelet Rich Fibrin In Human Mandibular Molar Grade II Furcation Defects- A Clinical and Radiological Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02430519
Acronym
PRFMMFD
Enrollment
22
Registered
2015-04-30
Start date
2012-09-30
Completion date
2013-05-31
Last updated
2017-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Keywords

Chronic Periodontitis, Clinical Parameters, Furcation defects, Radiographic bone fill

Brief summary

Background: Furcation is the bifurcation or trifurcation of a multirooted tooth. It is an area of complex anatomic morphology difficult to debride by routine periodontal instrumentation. Multiple approaches have been used in an effort to treat the furcation Choukroun's platelet-rich fibrin (PRF), a second generation platelet concentrate has biochemical components which have well known synergetic effects on healing processes. The present study was conducted to evaluate the effectiveness of autologous platelet-rich fibrin (PRF) in the treatment of mandibular molar Grade 2 furcation defects in comparison to allograft and guided tissue regeneration (GTR) membrane.

Detailed description

ABSTRACT Background: Furcation is the bifurcation or trifurcation of a multirooted tooth. It is an area of complex anatomic morphology difficult to debride by routine periodontal instrumentation. Multiple approaches have been used in an effort to treat the furcation Choukroun's platelet-rich fibrin (PRF), a second generation platelet concentrate has biochemical components which have well known synergetic effects on healing processes. The present study was conducted to evaluate the effectiveness of autologous platelet-rich fibrin (PRF) in the treatment of mandibular molar Grade 2 furcation defects in comparison to allograft and guided tissue regeneration (GTR) membrane. MATERIALS AND METHODS: The study was designed as a randomized, prospective, parallel-arm, interventional clinical trial wherein 30 patients with periodontitis and grade II Mandibular furcation defects attending the Out Patient wing of the Department of Periodontics of a tertiary referral care hospital were equally divided into group A and group B. Patients in.Group A, were treated by the placement of PRF as a Graft and as a membrane at the surgical site , while in Group B, the defects were treated by the placement of Allograft and Healiguide collagen membrane. Plaque Index, Probing depth, Vertical clinical attachment level, Horizontal clinical attachment level, Gingival marginal level, and amount of bonefill using Radiovisiography were recorded at baseline and 9 months. Intra-group comparison of Mean scores between Group A and Group B was done using Paired t test and Inter-group comparison using independent sample t test. CONCLUSION Further studies evaluating the efficacy of PRF using a larger sample size should be performed to evaluate its true beneficial effects on long term basis in patients with mandibular molar Grade 2 furcation defects.

Interventions

PROCEDUREFurcation Treatment with Allograft and GTR

Allograft and GTR placed into furcation after flap elevation and debridement

DEVICEallograft and guided tissue regeneration (GTR) membrane (DFDBM and Healiguide)
PROCEDUREFurcation treatment with PRF

PRF Placed into the furcation after flap elevation and debridement

Sponsors

Dr.Syed Asimuddin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

The eligible samples were screened and randomly assigned by lottery method by investigator KRR into PRF (Group A) and GTR + Allograft (Group B). The treatment was performed by investigator SA who was blinded to the randomization process

Intervention model description

Prospective, randomized, parallel arm, interventional trial

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* One or more sites showing grade II furcation involvement in mandibular molars, with Probing pocket depth ≥ 5mm * Vertical attachment level and horizontal level ≥3mm were considered. * Patients who were systemically healthy, with no history of endodontic and periodontal treatment for the last 6 months, and no antibiotic usage for the last 6 months were included in the study. Care was taken to ascertain that the samples taken for the study were not allergic to any drugs nor to the graft materials used.

Exclusion criteria

* Patients with a history of diabetes, hypertension, on anticoagulant or steroid therapy (which could alter the effects of PRF), cardiac diseases, insufficient platelet counts and immunocompromised individuals were excluded from the study. * Care was taken to exclude pregnant women and lactating mothers, smokers, patients with previous history of graft placement in the experimental site, and importantly those patients who were unable to maintain good oral hygiene (PI Score ≥ 1.5). * If Grade II mobility was observed after phase I therapy in the experimental teeth, they were excluded

Design outcomes

Primary

MeasureTime frameDescription
Vertical clinical attacment level9 months Post treatmentThe Vertical clinical attachment level was assessed preoperatively and 9 months after surgery
Horizontal clinical attachment level9 months Post treatmentThe horizontal clinical attachment level was assessed preoperatively and 9 months after surgery.
Bone fill9 months Post treatmentBone fill was assessed radiographically and 9 months after surgery

Secondary

MeasureTime frameDescription
Plaque Index9 Months Post treatmentPlaque index was assessed preoperatively and 9 months after surgery
Probing depth9 Months Post treatmentProbing depth was assessed preoperatively and 9 months after surgery
Gingival marginal level9 months post treatmentGingival marginal level was assessed preoperatively and 9 months after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026